Wedmont Private Capital Has $1.27 Million Stock Holdings in Colgate-Palmolive Company $CL

Wedmont Private Capital lifted its position in Colgate-Palmolive Company (NYSE:CL) by 70.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,440 shares of the company’s stock after buying an additional 6,813 shares during the quarter. Wedmont Private Capital’s holdings in Colgate-Palmolive were worth $1,267,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of CL. Vermillion & White Wealth Management Group LLC lifted its position in Colgate-Palmolive by 86.1% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock worth $30,000 after acquiring an additional 155 shares during the last quarter. Copia Wealth Management acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at about $29,000. Cloud Capital Management LLC acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $30,000. Global Wealth Strategies & Associates increased its position in Colgate-Palmolive by 300.0% in the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after buying an additional 300 shares during the period. Finally, Kelleher Financial Advisors acquired a new position in Colgate-Palmolive during the 3rd quarter valued at $35,000. 80.41% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares in the company, valued at approximately $1,018,691.15. This represents a 59.02% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares of the company’s stock, valued at $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 184,683 shares of company stock valued at $17,486,693. Company insiders own 0.41% of the company’s stock.

Analysts Set New Price Targets

CL has been the topic of several research reports. Jefferies Financial Group boosted their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Bank of America lifted their target price on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. UBS Group boosted their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research note on Wednesday, January 14th. Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price objective for the company in a research report on Tuesday, December 9th. Finally, The Goldman Sachs Group reissued a “buy” rating and set a $100.00 price objective on shares of Colgate-Palmolive in a report on Friday, February 20th. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $94.75.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $85.14 on Monday. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The firm has a market capitalization of $68.62 billion, a PE ratio of 32.49, a price-to-earnings-growth ratio of 3.81 and a beta of 0.28. The firm has a 50-day moving average price of $91.01 and a 200 day moving average price of $83.36.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the previous year, the business earned $0.91 earnings per share. The company’s quarterly revenue was up 5.8% on a year-over-year basis. Research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be given a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.